We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+9.84%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.1B
AUM Growth
+$1.16B
(+5.5%)
Cap. Flow
-$352M
Cap. Flow
% of AUM
-1.59%
Top 10 Holdings %
Top 10 Hldgs %
19%
Holding
2,132
New
129
Increased
562
Reduced
821
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halliburton
HAL
|
+$43.5M |
| 2 |
Verisk Analytics
VRSK
|
+$39.9M |
| 3 |
KNBE
KnowBe4, Inc. Class A Common Stock
KNBE
|
+$38.6M |
| 4 |
Biogen
BIIB
|
+$38.6M |
| 5 |
VICI Properties
VICI
|
+$34.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$65.7M |
| 2 |
Apple
AAPL
|
+$53.4M |
| 3 |
PayPal
PYPL
|
+$37.7M |
| 4 |
Reinsurance Group of America
RGA
|
+$36.6M |
| 5 |
SLB Ltd
SLB
|
+$31.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.64% |
| 2 | Healthcare | 14.95% |
| 3 | Financials | 14.29% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Real Estate | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Moelis & Co
MC
$4.85B
| $963K | ﹤0.01% |
25,100
-3,400
| -12% | -$138K |
|
952
Amkor Technology
AMKR
$10.6B
| $961K | ﹤0.01% |
40,100
-13,100
| -25% | -$304K |
|
953
Iridium Communications
IRDM
$4.7B
| $961K | ﹤0.01% |
18,700
+1,500
| +9% | +$75.3K |
|
954
Marqeta
MQ
$1.93B
| $961K | ﹤0.01% |
39,325
+3,025
| +8% | +$82.6K |
|
955
Coca-Cola Femsa
KOF
$22.5B
| $950K | ﹤0.01% |
14,000
| – | – |
|
956
Liberty Energy
LBRT
$2.79B
| $949K | ﹤0.01% |
59,300
-13,100
| -18% | -$208K |
|
957
Nu Skin
NUS
$257M
| $948K | ﹤0.01% |
22,500
-3,400
| -13% | -$131K |
|
958
AbCellera Biologics
ABCL
$1.65B
| $946K | ﹤0.01% |
93,400
-6,400
| -6% | -$73.9K |
|
959
Extreme Networks
EXTR
$3.8B
| $944K | ﹤0.01% |
51,600
-4,400
| -8% | -$77.1K |
|
960
NETSCOUT
NTCT
$2.83B
| $942K | ﹤0.01% |
29,000
-2,900
| -9% | -$100K |
|
961
Denali Therapeutics
DNLI
$3.79B
| $937K | ﹤0.01% |
33,700
| – | – |
|
962
WesBanco
WSBC
$4.02B
| $935K | ﹤0.01% |
25,300
-3,100
| -11% | -$119K |
|
963
Adient
ADNT
$1.69B
| $933K | ﹤0.01% |
26,900
+16,300
| +154% | +$570K |
|
|
UHT
964
Universal Health Realty Income Trust
UHT
$621M
| $933K | ﹤0.01% |
19,552
+2,905
| +17% | +$140K |
|
|
CNR
965
Core Natural Resources Inc
CNR
$3.93B
| $929K | ﹤0.01% |
14,300
-2,400
| -14% | -$162K |
|
966
Towne Bank
TOWN
$3.54B
| $928K | ﹤0.01% |
30,100
-4,200
| -12% | -$130K |
|
967
Hamilton Lane
HLNE
$3.88B
| $926K | ﹤0.01% |
14,500
-1,400
| -9% | -$93.1K |
|
968
Louisiana-Pacific
LPX
$5.14B
| $925K | ﹤0.01% |
15,629
-5,595
| -26% | -$330K |
|
969
Renasant Corp
RNST
$4.04B
| $917K | ﹤0.01% |
24,400
-4,200
| -15% | -$159K |
|
970
Sarepta Therapeutics
SRPT
$1.64B
| $917K | ﹤0.01% |
7,079
+477
| +7% | +$55.3K |
|
971
Acadia Pharmaceuticals
ACAD
$4.51B
| $916K | ﹤0.01% |
57,600
| – | – |
|
|
HTLF
972
DELISTED
Heartland Financial USA, Inc.
HTLF
| $913K | ﹤0.01% |
19,600
-2,000
| -9% | -$94.5K |
|
973
AtriCure
ATRC
$2.08B
| $909K | ﹤0.01% |
20,500
| – | – |
|
974
AeroVironment
AVAV
$7.19B
| $907K | ﹤0.01% |
10,600
+6,400
| +152% | +$547K |
|
|
CPRX
975
DELISTED
Catalyst Pharmaceutical
CPRX
| $905K | ﹤0.01% |
48,700
-13,700
| -22% | -$211K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q4 2022 Portfolio in Review
As of Q4 2022, STRS Ohio held 2,132 positions worth $22.1B, up 5.5% from $21B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
STRS Ohio's Q4 2022 filing shows 129 new, 562 increased, 821 reduced and 155 closed positions. Its largest new stake was Biogen: 136,550 shares worth $37.8M. The largest sale was Microsoft, an estimated $65.7M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
- STRS Ohio's largest Q4 2022 buy was Biogen: 136,550 shares worth $37.8M.
- STRS Ohio added most to Halliburton in Q4 2022, an estimated $43.5M increase.
- STRS Ohio's biggest Q4 2022 reduction was Microsoft, cutting an estimated $65.7M.
- STRS Ohio fully exited Abiomed Inc in Q4 2022, selling an estimated $23.7M.
- STRS Ohio's ten largest holdings make up 19% of its $22.1B portfolio in Q4 2022.
- STRS Ohio opened 129 new positions and closed 155 in Q4 2022.
- STRS Ohio's portfolio value rose 5.5% quarter-over-quarter to $22.1B.
Based on STRS Ohio's 13F filing for Q4 2022, filed 26 Jan 2023.